HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
about
Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes.Therapeutic effects of hyaluronidase on acquired lymphedema using a newly developed mouse limb model.Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
P2860
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
@ast
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
@en
type
label
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
@ast
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
@en
prefLabel
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
@ast
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
@en
P2093
P2860
P356
P1476
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.
@en
P2093
Bolot Mambetsariev
Frances E Lennon
Joshua E Berlind
Nurbek Mambetsariev
Patrick A Singleton
Tamara Mirzapoiazova
P2860
P356
10.3389/FONC.2015.00164
P50
P577
2015-07-21T00:00:00Z